Stockscreener 앱 받기
0.8126
14.01%
-0.1346
전일 마감가:
$0.9472
열려 있는:
$0.8623
하루 거래량:
1.31M
Relative Volume:
0.15
시가총액:
$38.20M
수익:
$3.50M
순이익/손실:
$-37.33M
주가수익비율:
-1.5627
EPS:
-0.52
순현금흐름:
$-19.15M
1주 성능:
+163.59%
1개월 성능:
+51.93%
6개월 성능:
-26.34%
1년 성능:
-25.28%
1일 변동 폭
$0.7672
$0.8694
1주일 범위
$0.2801
$2.52
52주 변동 폭
$0.2761
$2.52
Hcw Biologics Inc Stock (HCWB) Company Profile
명칭
Hcw Biologics Inc
전화
954-842-2024
주소
2929 N COMMERCE PKWY, MIRAMAR
HCWB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| HCWB | 0.8199 | 38.20M | 3.50M | -37.33M | -19.15M | -0.52 |
| VRTX | 448.33 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 744.03 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 590.33 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 249.50 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 103.75 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Hcw Biologics Inc 주식(HCWB)의 최신 뉴스
HCW Biologics takes aim at CD8+ in deal with WY Biotech - The Pharma Letter
HCW Biologics : Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules Form 8 K - Marketscreener.com
HCW Biologics Expands with New Financial Agreements - TipRanks
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.13% - MSN
HCW Biologics prices $6.9M registered direct offering at $1.03 per share - Yahoo Finance
Why Symbotic Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket - Benzinga
Spotlight on Undervalued Nasdaq Stocks: HCWB, CRDL, NIVF, SINT, APLMA Must-Watch This Week! - Marketscreener.com
HCW Biologics announces pricing of $6.9M registered direct offering, concurrent private placement - MSN
HCW Biologics Secures $6.9M Above-Market Offering with Warrant Coverage | HCWB Stock News - StockTitan
HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules - Benzinga
HCW Biologics Announces Pricing of $6.9 Million Registered - GlobeNewswire
Aclaris Therapeutics (ACRS): Strategic Alliance with Biosion Ignites 53% Stock Surge - BP Journal
Sintx Technologies, Inc. (SINT): A Bold Move with Strategic Stock Repurchase Program Boosts Investor Confidence - BP Journal
HCW Biologics Inc. (HCWB): A Strategic Leap with Worldwide Licensing Agreement Sends Stock Up Over 310% - BP Journal
U.S. STOCKS Henry Schein Inc, Palantir Technologies, Uber Technologies - XM
Owning 44% shares,institutional owners seem interested in Jamieson Wellness Inc. (TSE:JWEL), - Yahoo Finance
HCW Biologics signs licensing deal with WY Biotech - Investing.com India
Trinity Investors Managing Partner Sanjay Chandra Named One of Dallas Most Influential Leaders on DCEO’s Dallas 500 List - Yahoo Finance
HCW Biologics Shares Surge on License Agreement - MarketWatch
Broward pharma developer inks $7 million deal with Chinese firm - The Business Journals
Enphase Energy Powers Up with US-Made IQ Batteries: Unlocking Bonus Tax Credits - AOL
California logistics company files for Chapter 11 - Yahoo Finance
Crude Oil Rises Sharply; US Homebuilder Sentiment Surges In November - Benzinga
Spirit Airlines Declares Bankruptcy After Failed Merger and Rising Costs - Yahoo Finance
Stock Market News: HCW Biologics increase by 521.18% while CareMax drops by 49.20% during mid day trading - Business Upturn
Ultra low-cost carrier Spirit Airlines files for bankruptcy - Yahoo Finance
U.S. STOCKS Tesla Inc, Palantir Technologies and Super Micro Computer Inc - XM
Nvidia Stock Drops on Report of Snag With Blackwell Chip Servers - Yahoo Finance
Why Is Penny Stock HCW Biologics Surging On Monday? - Yahoo Finance
Dow Falls 100 Points; Brady Posts Upbeat Results - Benzinga
Stock market today: CareMax(−41.19%), HCW Biologics(+209.06%) among the most volatile stocks in early trading - Business Upturn
HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate - GlobeNewswire
This tiny U.S biotech has made a big deal in China - RagingBull
Kandi Technologies Reports Third Quarter 2024 Financial Results - The Manila Times
HCW Biologics jumps on license agreement for immunotherapeutic product candidate - Seeking Alpha
MedinCell And 2 Other Top Growth Stocks With Strong Insider Ownership - Yahoo Finance
HCW Biologics Inc. and Wy Biotech Announce License Agreement for Immunotherapeutic Product Candidate - Marketscreener.com
Here's What Analysts Are Forecasting For ESCO Technologies Inc. (NYSE:ESE) After Its Yearly Results - Yahoo Finance
dynaCERT Third Quarter 2024 Earnings: CA$0.008 loss per share (vs CA$0.004 loss in 3Q 2023) - Yahoo Finance
Armlogi Holding First Quarter 2025 Earnings: US$0.11 loss per share (vs US$0.069 profit in 1Q 2024) - Yahoo Finance
HCW Biologics Third Quarter 2024 Earnings: US$0.10 loss per share (vs US$0.14 loss in 3Q 2023) - Simply Wall St
There's Been No Shortage Of Growth Recently For Royal Caribbean Cruises' (NYSE:RCL) Returns On Capital - Yahoo Finance
Samko Timber Third Quarter 2024 Earnings: Rp16.00 loss per share (vs Rp105 loss in 3Q 2023) - Yahoo Finance
Applied Materials Shares Slide on Disappointing Sales Forecast - Yahoo Finance
Analysts Have Made A Financial Statement On FiscalNote Holdings, Inc.'s (NYSE:NOTE) Third-Quarter Report - Yahoo Finance
OptiNose, Inc. (NASDAQ:OPTN) Just Reported, And Analysts Assigned A US$3.50 Price Target - Yahoo Finance
GCM Grosvenor (NASDAQ:GCMG) Is Paying Out A Dividend Of $0.11 - Yahoo Finance
November 2024 US Exchange Standouts: Promising Penny Stocks - Yahoo Finance
HCW Biologics Inc. (HCWB) Quarterly 10-Q Report - Quartz
HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights - The Manila Times
HCW Biologics Q3 Revenue Falls 50%, Faces $14.4M Legal Obligations Amid Going Concern | HCWB Stock News - StockTitan
Hcw Biologics Inc (HCWB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
0.16%
자본화:
|
볼륨(24시간):